论文部分内容阅读
高白细胞性急性髓性白血病(hyperleukocytic a-cute myeloid leukemia,HAML)患者在接受诱导化疗时,容易发生危及生命的并发症,死亡率(treatment related mortality,TRM)高。多数医院先采用白细胞
Patients with hyperleukocytic a-cute myeloid leukemia (HAML) are prone to life-threatening complications when receiving induction chemotherapy and have high treatment related mortality (TRM). Most hospitals use white blood cells